Bryn Mawr Trust CO Royalty Pharma PLC Transaction History
Bryn Mawr Trust CO
- $5.88 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in Royalty Pharma PLC stock. As of the latest transaction made, Bryn Mawr Trust CO holds 106,656 shares of RPRX stock, worth $4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
106,656
Previous 107,448
0.74%
Holding current value
$4 Million
Previous $3.87 Million
2.82%
% of portfolio
0.06%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding RPRX
# of Institutions
507Shares Held
308MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.75 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.37 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$864 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$821 Million0.14% of portfolio
-
Baillie Gifford & CO17.4MShares$652 Million0.48% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...